Skip to content

Comparative study of Vacha churna and Sarpagandha churna in management of hypertension

Effect of Vacha churna as compared to Sarpagandha churna in the management of stage-1 essential Hypertension:A randomised controlled trial - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076722
Enrollment
60
Registered
2024-11-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

Vd Rekha Gajanan Mehenge
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed patients of stage -1 essential hypertension.

Exclusion criteria

Exclusion criteria: Secondary hypertension

Design outcomes

Primary

MeasureTime frame
Vacha churna is more effective than Sarpagandha churna in the management of stage-1 essential hypertensionTimepoint: at the end of 30 days

Secondary

MeasureTime frame
Sarpagandha churna is more effective than Vacha churna in the management of stage-1 essential hypertensionTimepoint: At the end of 30 days

Countries

India

Contacts

Public ContactVd Mrityunjay Sharma

Shri ayurved mahavidyalaya nagpur

mrityunjaysharma22@gmail.com9373103182

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026